Chinook Therapeutics Inc Cvr (ADRO)
EBITDA Growth
37.63%
Quarterly · Period ending:
ADRO EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported37.63%period ending
Latest reported37.63%period ending
ADRO Quarterly EBITDA YoY % (-158.70% → 37.63%)
Year-over-year change
High-resolution chart · PNG
ADRO ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| 37.628% | |
| 10.0707% | |
| 45.5339% | |
| 27.9262% | |
| 1.4172% | |
| 25.0173% | |
| -9.6081% | |
| 2.4562% | |
| 18.5081% | |
| -4.3611% | |
| 14.0685% | |
| -10.5844% | |
| -20.2576% | |
| -617.9254% | |
| 5.9784% | |
| -804.8459% | |
| -3,220.9877% | |
| 116.4154% | |
| -51.9518% | |
| 115.7929% | |
| -913.3385% | |
| -158.6974% |